1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Angel Studios amended and restated its merger agreements to acquire Tuttle Twins Show, LLC (TTS) and Toothy Cow Productions, LLC (TCP), both signed November 14, 2025. The changes extend the outside date to October 31, 2026, and alter several closing conditions and the TCP merger structure. Company insiders and affiliates hold units in both companies and would receive Class A shares in the deals, and the company has already provided funding to both.
Outside date for both the TTS and TCP mergers extended to October 31, 2026
Closing condition requiring a showrunner agreement for Daniel Harmon removed from the TTS deal
Company related parties own 41.6% of TTS units and 2.4% of TCP units as of June 23, 2026
Company has provided $11.7 million to TTS and $11.9 million to TCP to date, with a maximum TCP funding commitment of $11.9 million
Rani Therapeutics appointed Nicholas M. Maestas as Chief Financial Officer, succeeding Svai Sanford, who had previously announced he would step down once a successor was named. The company also approved a 2026 Equity Inducement Plan reserving 5,500,000 Class A shares for new-hire awards, which does not require stockholder approval.
Maestas, age 46, was CFO and Head of Corporate Strategy at Tempest Therapeutics from January 2025 until June 2026.
Offer letter dated June 24, 2026 sets an annual base salary of $500,000 and a target bonus of 75% of base salary.
Maestas will receive a non-qualified option to purchase 2,000,000 Class A shares, vesting over four years.
The Board approved the Inducement Plan on June 28, 2026, reserving 5,500,000 shares.
On June 27, 2026, Martin Marietta agreed to acquire all equity interests in Lhoist North America from LNA Holding for $13.5 billion, consisting of $7 billion in cash and 10,953,543 newly issued Martin Marietta shares valued at $6.5 billion. After closing, LNA Holding is expected to hold about 15% of Martin Marietta's common stock, and the company has a $7.0 billion bridge loan commitment to fund the cash portion, so shareholders would face a larger share count and significant new borrowing if the deal closes.
Total consideration is $13.5 billion: $7 billion in cash plus 10,953,543 shares valued at $6.5 billion, based on the 15-day volume-weighted average price ending June 26, 2026
Closing requires expiration or termination of the Hart-Scott-Rodino waiting period and other regulatory approvals; long stop date is October 31, 2026, extendable to June 15, 2027
Martin Marietta would pay a $350 million termination fee if the deal ends under specified circumstances tied to failure to obtain regulatory clearances by the Extended Long Stop Date
A 364-day, $7.0 billion unsecured bridge facility from Goldman Sachs Bank USA and Goldman Sachs Lending Partners LLC is committed to finance the cash consideration
Four Corteva directors, Karen Grimes, Marcos Lutz, Charles Magro and Kerry Preete, agreed to resign from the Corteva board effective immediately before the planned spin-off of the seed business into Vylor, Inc. The filing says each is expected to join the Vylor board, and the resignations are not tied to any disagreement with the company. The companies also announced their post-separation boards, and the separation remains on track for the fourth quarter of 2026.
Resignations agreed June 26, 2026, and take effect only if the spin-off is completed
Greg Page to chair a nine-person Corteva board; Luke Kissam to join at separation
Karen Grimes to chair a seven-director Vylor board; a search is ongoing for at least one more member
Vylor filed its first Form 10 registration statement with the SEC; separation on track for 4Q 2026
TransAct Technologies appointed Troy W. Ingianni, formerly Vice President, Global Controller and Chief Accounting Officer at Barnes Group, as Chief Financial Officer, Secretary and Treasurer effective July 1, 2026, replacing Steven DeMartino, who retires from those roles June 30, 2026. The Board's earlier choice of Controller Robert Campbell for the role was withdrawn for personal reasons, and Mr. Ingianni also takes over as Principal Accounting Officer.
Ingianni's offer letter sets a base salary of $350,000 (prorated for 2026) and a target bonus of 35% of base salary.
He will receive 15,000 restricted stock units vesting in four equal annual installments.
Severance is six months' base salary for termination without cause, or 12 months' base salary following a change in control.
John M. Dillon, CEO, will also take the title of President upon DeMartino's retirement.
Midera Food Processing, a Middleby subsidiary, entered a five-year, $1.0 billion revolving credit agreement with Bank of America as administrative agent on June 29, 2026, in connection with its planned spin-off. The Borrower used borrowings and cash on hand to make a $233 million distribution to a Middleby subsidiary, and the spin-off is expected to take effect July 6, 2026, which means shareholders of Middleby will receive Midera shares and Midera will carry this new debt.
$1.0 billion facility: $750 million U.S. dollar revolver and $250 million multi-currency revolver, maturing June 29, 2031.
Before the spin-off takes effect, borrowings may not exceed $300 million; if the spin-off does not occur, commitments terminate within 15 business days.
The Borrower used borrowings and cash on hand to make a $233 million distribution to Middleby Marshall Inc., a Middleby subsidiary.
Middleby shareholders of record at 12:01 a.m. Eastern Time on July 6, 2026 are expected to receive Midera shares.
AeroVironment reported fiscal fourth-quarter 2026 revenue of $641.6 million, up 133% from $275.1 million, and net income of $63.2 million, or $1.25 per diluted share. For the full fiscal year, revenue rose 141% to $1,976.8 million, but the company posted a net loss of $265.1 million, or $5.40 per share, after a $240.7 million goodwill impairment. For fiscal 2027, the company expects revenue of $2.125 billion to $2.225 billion and net income of $8 million to $24 million.
Q4 fiscal 2026 revenue of $641.6 million; net income of $63.2 million, or $1.25 per diluted share, versus $16.7 million, or $0.59, a year earlier
Full-year fiscal 2026 net loss of $265.1 million, or $5.40 per diluted share, including a $240.7 million goodwill impairment
Fiscal 2027 guidance: revenue of $2.125 billion to $2.225 billion; net income of $8 million to $24 million; GAAP EPS of $0.16 to $0.48
Funded backlog of $1.2 billion as of April 30, 2026, versus $726.6 million a year earlier
Synchrony Financial announced executive leadership changes effective June 29, 2026. Carol Juel, formerly Executive Vice President, Chief Technology and Operating Officer, becomes Executive Vice President and Chief Executive Officer of the Digital platform, succeeding Bart Schaller, who plans to retire after a 35-year career. The company also promoted Florin Arghirescu to Chief Technology Officer and expanded DJ Casto's role to include Operations.
Carol Juel named EVP and CEO of the Digital platform, succeeding Bart Schaller, effective June 29, 2026
Florin Arghirescu promoted to EVP and Chief Technology Officer, reporting to CEO Brian Doubles
DJ Casto appointed EVP, Chief People and Operations Officer, adding servicing, collections and customer care to Human Resources
Copart's board appointed Executive Chairman A. Jayson Adair as chief executive effective July 31, 2026, replacing Jeffrey Liaw, who will also resign from the board. The filing discloses a transition agreement for Liaw with a $450,000 lump sum, $200,000 paid during a transition period through July 31, 2027, and additional conditional severance and equity benefits, which shareholders may weigh as part of the leadership change.
Adair, who previously led Copart as CEO, takes over on July 31, 2026, and Liaw steps down as CEO and director on the same date.
Liaw's transition agreement provides a $450,000 lump sum and $200,000 during the transition period, subject to a general release.
Liaw's conditional severance includes $250,000, accelerated vesting of remaining equity awards, and an extension of stock option exercise periods.
Adair is the son-in-law of Chairman Wills J. Johnson, a relationship the filing says is disclosed in the 2025 proxy statement.
Fortune Brands Innovations appointed Jesse Singh, former CEO of The AZEK Company, as chief executive and a board member, effective June 29, 2026. Interim CEO David Barry was named Executive Vice President and Chief Operating Officer, and the company has begun a strategic review of its Fiberon business.
Singh's base salary is $1,100,000, with a bonus target of 150% of salary and an annual long-term incentive target of $6,700,000.
Singh's inducement awards, granted July 1, 2026, cover 850,000 performance-based RSUs and a 300,000-share stock option award.
Barry receives a performance-based RSU award with a target grant value of $1,200,000 and a 25,000-share option award as COO.
Interim CFO Ashley George will remain in her role while the search for a permanent CFO continues.
SandRidge Energy's subsidiary signed a purchase agreement on June 26, 2026, to acquire oil and gas properties in the Cherokee Play from Rockies Resources Holdings LLC for $65 million in cash, plus three contingent earn-out payments of $2 million each. The company expects to fund the deal with cash on hand and close it in the third quarter of 2026, subject to customary closing conditions. The filing does not report financial results from the assets, so shareholders have no figures yet on how the deal will affect revenue or earnings.
Cash consideration of $65 million at closing, subject to customary purchase price adjustments
Three contingent earn-out payments of $2 million each, tied to WTI crude oil price thresholds from July 1, 2026 through December 31, 2027
Acquired assets include net production of about 3.0 MBoed (about 43% oil), about 7,000 net leasehold acres, interests in 21 wells and eight proven development locations
Expected closing in the third quarter of 2026; the press release says the effective date is May 1, 2026
JATT II Acquisition Corp., a blank check company, entered a business combination agreement with Talawar Tx Inc., a biotechnology developer of bispecific antibodies. The combined company is expected to trade on Nasdaq as TLWR and to receive up to $285 million before transaction costs, including a $225 million PIPE financing at $10.00 per share, if there are no redemptions by JATT II shareholders.
Business combination agreement signed June 29, 2026; JATT II shareholders must approve the deal, and closing is expected in the second half of 2026
Expected proceeds of $285 million before transaction costs, assuming no redemptions: $60 million from the JATT II trust account plus a $225 million PIPE
Combined company expected to trade on Nasdaq Capital Market under ticker TLWR; lead asset TALA-125 targets clinic entry in Q1 2027
Rocket Lab agreed on June 28, 2026 to acquire Iridium Communications in a cash and stock deal valued at $54 per Iridium share and an enterprise value of about $8.0 billion. Iridium holders would receive $27.00 in cash plus Rocket Lab stock, with the stock portion set by an exchange ratio that is subject to a collar between $67.50 and $112.50 per Rocket Lab share. The deal requires Iridium shareholder approval and regulatory clearances and is expected to close in mid-2027, and it is funded partly by a $3.6 billion bridge loan commitment.
Iridium holders receive $27.00 in cash plus Rocket Lab shares at an exchange ratio that is fixed at 0.4000 if the Rocket Lab price is $67.50 or below and at 0.2400 if it is $112.50 or above.
Iridium would pay Rocket Lab a $223.62 million termination fee in specified circumstances, including if its board withdraws support for the deal.
Rocket Lab has a 364-day senior secured bridge term loan commitment of $3.6 billion from Deutsche Bank and Wells Fargo.
The transaction is expected to close in mid-2027 and must be approved by a majority of Iridium's outstanding shares.
On June 28, 2026, Iridium agreed to merge with Rocket Lab, which will acquire all outstanding Iridium common stock for $27.00 in cash plus Rocket Lab shares per Iridium share. The companies put the notional value at $54.00 per share and the enterprise value at approximately $8.0 billion, and the deal requires an Iridium stockholder vote, antitrust clearance, and FCC consent. Iridium would owe Rocket Lab a $223.62 million termination fee in specified circumstances, and its shares would be delisted from Nasdaq if the deal closes.
Each Iridium share receives $27.00 in cash plus Rocket Lab stock; the exchange ratio is fixed at 0.4000 if the Rocket Lab price is $67.50 or less and at 0.2400 if it is $112.50 or more.
The transaction is expected to close in mid-2027, with an outside date of June 28, 2027, extendable to December 28, 2027.
Iridium would pay Rocket Lab a $223.62 million termination fee under specified circumstances, including if its board withdraws its recommendation.
Rocket Lab has received commitments for a $3.6 billion 364-day senior secured bridge term loan from Deutsche Bank and Wells Fargo.
BioCryst said its board approved on June 25, 2026 a plan to discontinue internal discovery programs and close its Birmingham, Alabama facility, with the work substantially complete by the end of 2026. The company cannot yet estimate the total cost of the plan and will file an amendment once it does, while lowering its 2026 non-GAAP operating expense guidance and reaffirming revenue guidance.
Board approved the plan on June 25, 2026; implementation expected to be substantially complete by the end of 2026.
Total costs of the plan are not yet estimated; expected costs include contract, lease and employee termination and severance.
2026 non-GAAP operating expense guidance lowered to $420 million to $440 million from $450 million to $470 million.
Total 2026 revenue guidance of $635 million to $660 million is reaffirmed; ORLADEYO oral pellets expected to be available in early August 2026.
Honeywell completed the spin-off of its Aerospace business effective 12:01 a.m. New York time on June 29, 2026, making Honeywell Aerospace Inc. an independent public company that began regular-way trading on Nasdaq that day. The 8-K also covers agreements with Honeywell on separation, transition services, taxes, employee matters, intellectual property and trademarks, and supplemental unaudited quarterly results for 2024 and 2025 showing full-year 2025 net sales up but net income attributable to the company down.
Distribution: one share of Honeywell Aerospace common stock for every two Honeywell common shares held at the close of business on June 15, 2026; fractional shares were sold and cash paid instead.
Trading began on Nasdaq under HONA on June 29, 2026, with CUSIP 43849R105. Honeywell continues as Honeywell Technologies.
FY 2025 net sales were $17,404 million versus $15,445 million in FY 2024, while net income attributable to Honeywell Aerospace was $2,687 million versus $2,817 million.
Genesco said Jonathan Collins will become Senior Vice President, Finance and Chief Financial Officer on August 3, 2026, and serve as principal financial officer from that date. Board Chair, President and CEO Mimi E. Vaughn, who has been interim CFO since March 2026, will stop serving in that role on the same date. The filing sets out Collins' pay package, which includes a $550,000 base salary and a $1,787,500 initial total direct compensation at target.
Collins' annual base salary is $550,000, with a Fiscal 2027 short-term incentive target of $412,500 and a long-term incentive target of $825,000.
Collins previously served as CFO of America's Car-Mart, Inc. from May 2025, and spent 2012 to 2025 at Walmart Inc., including as CFO of Walmart Africa.
Vaughn, who served as interim CFO since March 2026, will no longer be interim CFO or principal financial officer as of August 3, 2026.
Collins will receive a $25,000 quarterly relocation stipend, payable for three quarters.
Honeywell completed the spin-off of its Aerospace Technologies business, which now operates as Honeywell Aerospace (HONA), effective June 29, 2026. The parent now operates as Honeywell Technologies and continues to trade on Nasdaq as HON, and a 1-for-2 reverse stock split of its common stock took effect the same day. Shareholders should note the parent no longer consolidates Aerospace and that the share count was halved.
Spin-off effective 12:01 a.m. New York City time on June 29, 2026; Honeywell Aerospace began regular-way trading on Nasdaq as HONA that day.
Distribution ratio was one Aerospace share for every two Honeywell shares held at the close of business on the June 15, 2026 record date.
Reverse split reduced shares outstanding from about 634 million (March 31, 2026) to about 317 million; authorized shares cut from 2 billion to 1 billion.
Exhibit 99.2 recasts results: continuing-operations segment profit was $944 million in Q1 2026 versus $793 million in Q1 2025, and CEO James Currier resigned as an executive officer to lead Honeywell Aerospace.
Larimar Therapeutics said it has submitted the first module of a rolling Biologics License Application to the FDA for accelerated approval of nomlabofusp, after FDA meeting minutes said the existing data package appears sufficient for submission. The company also reported longer-term open label data, which showed improvements in some clinical measures alongside anaphylaxis in 10 of 43 patients, a safety finding shareholders should weigh.
First module of the rolling BLA submitted; remaining modules expected in the second half of 2026.
FDA meeting minutes say the existing data package appears sufficient for a BLA seeking accelerated approval; approval will be a matter of review.
Anaphylaxis occurred in 10 of 43 patients in the open label study, 9 of whom had prior exposure to nomlabofusp.
At 1 year, 100% (9/9) of participants had skin FXN levels above 50% of healthy volunteer mean; first patient dosing in a global Phase 3 study is expected in Q3 2026.
Verizon signed a transaction agreement on June 28, 2026 with BT Group and NewCo to combine its international wireline connectivity and managed network services business with BT's equivalent business, with each company holding 50% of NewCo. Verizon will also make a $625 million cash payment to NewCo, which will pass it to BT, and it expects a second-quarter 2026 estimated loss of $700 million to $800 million, plus severance and asset charges, that will weigh on reported results.
Transaction agreement signed June 28, 2026; closing is subject to customary regulatory approvals and closing conditions.
Verizon to pay $625 million in cash to NewCo; the value of each contributed business is subject to adjustment for cash, net working capital and indebtedness at closing.
Expected second-quarter 2026 estimated loss of $700 million to $800 million from classifying the Verizon Contributed Business as held for sale.
Severance charge of $350 million to $450 million and asset rationalization charges of $200 million to $300 million expected in the second quarter of 2026.
On June 27, 2026, Korn Ferry agreed to acquire AMS, a talent and consulting firm, for about £850 million (about $1.1 billion), with about $881 million in cash and about $255 million in Korn Ferry common stock. Closing requires regulatory approvals and is expected in the fiscal quarter ending October 30, 2026. Shareholders will see new shares issued and cash funded partly by revolver borrowings, and the company expects the deal to be immediately accretive to earnings per share in the first full year after adjusting for restructuring, integration and transaction costs.
Total price is about £850 million (about $1.1 billion): about $881 million in cash and about $255 million in Korn Ferry shares.
Cash funding is about $300 million from cash on hand and about $581 million from borrowings under the existing revolver.
AMS has about $650 million of run-rate fee revenue and $100 million of Adjusted EBITDA, according to the press release.
Closing requires HSR waiting period expiry and UK and German approvals, and may be terminated if conditions are not met within 180 days of signing.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.